Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes

Clinical Cancer Research

Volumn 12, Issue 13, 2006, Pages 4043-4054

  Cutz, Jean Claude ^a,b   Guan, Jun ^a   Bayani, Jane ^b   Yoshimoto, Maisa ^b   Xue, Hui ^a   Sutcliffe, Margaret ^a   English, John ^a   Flint, Julia ^a   LeRiche, Jean ^a   Yee, John ^a   Squire, Jeremy A ^b,c   Gout, Peter W ^a   Lam, Stephen ^a   Wang, Yu Zhuo ^a,d  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Department of Laboratory Medicine and Pathobiology ^*  (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CARCINOSARCOMA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; KIDNEY CAPSULE; LARGE CELL CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SPECTRAL KARYOTYPING; SQUAMOUS CELL CARCINOMA; STROMA CELL; TRANSPLANTATION; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

AGED; ANIMALS; CELL LINE, TUMOR; CYTOGENETIC ANALYSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MIDDLE AGED; SUBRENAL CAPSULE ASSAY; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33746068275     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0252     Document Type: Article

References (35)

1. Travis WD, Pathology of lung cancer. Clin Chest Med 2002;23:65-81.
2. Kerbel RS. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2003;2:S134-9.
3. Gazdar AF, Oie HK. Cell culture methods for human lung cancer. Cancer Genet Cytogenet 1986;19:5-10.
4. Phelps RM, Johnson BE, Ihde DC, et al. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl 1996;24:32-91.
5. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7.
6. Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003;9:4227-39.
7. Wang YZ, Revelo MP, Sudilovsky D, et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005;64:149-59.
8. Bogden AE, Haskell PM, LePage DJ, Kelton DE, Cobb WR, Esber HJ. Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. Exp Cell Biol 1979;47:281-93.
9. Liou LS, Zhou Y, Wang Y, et al. A living human tumor bank using an orthotopic xenograft mouse model: feasibility and implications of angiogenesis and proliferation [abstract]. J Urol 2004;171:208.
10. Lee CH, Xue H, Sutcliffe M, et al. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models. Gynecol Oncol 2005;96:48-55.
11. Wang Y, Xue H, Cutz J-C, et al. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest 2005;85:1392-404.
12. Bayani J, Squire JA. Cell Biology of Chromosomes and Nuclei. In: Morgan K, editor. Current Protocols in Cell Biology. New York (NY): John Wiley and Sons Inc.; 2004. p 22.2.1-11.
13. Bayani J, Zielenska M, Pandita A, et al. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 2003;36:7-16.
14. Schrock E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
15. Mitelman F. ISCN 1995 An international system for human cytogenetic nomenclature (1995). New York: S. Karger: 1995.
16. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999;96:4494-9.
17. Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, et al. SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. Am J Pathol 2002;161:43-51.
18. Van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003;82:539-48.
19. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 1999;17:343-59.
20. Sy SM, Wong N, Lee TW, et al. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer 2004;40:1082-94.
21. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 2001;125:87-99.
22. Berrieman HK, Ashman JN, Cowen ME, Greenman J, Lind MJ, Cawkell L. Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. Br J Cancer 2004;90:900-5.
23. Ashman JN, Brigham J, Cowen ME, et al. Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization. Int J Cancer 2002;102:230-6.
24. Grigorova M, Lyman RC, Caldas C, Edwards PA. Chromosome abnormalities in 10 lung cancer cell lines of the NCl-H series analyzed with spectral karyotyping. Cancer Genet Cytogenet 2005;162:1-9.
25. Tai AL, Fang Y, Sham JS, et al. Establishment and characterization of a human non-small cell lung cancer cell line. Oncol Rep 2005;13:1029-32.
26. Sy SM, Fan B, Lee TW, et al. Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers. Cancer Genet Cytogenet 2004;153:57-9.
27. Dennis TR, Stock AD. A molecular cytogenetic study of chromosome 3 rearrangements in small cell lung cancer: consistent involvement of chromosome band 3q13.2. Cancer Genet Cytogenet 1999;113:134-40.
28. Sargent LM, Senft JR, Lowry DT, et al. Specific chromosomal aberrations in mouse lung adenocarcinoma cell lines detected by spectral karyotyping: a comparison with human lung adenocarcinoma. Cancer Res 2002;62:1152-7.
29. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-83.
30. Brennan J, O'Connor T, Makuch RW, et al. Myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 1991;51:1708-12.
31. Zajac-Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer 2001;34:543-6.
32. Bonnet D. Cancer stem cells: lessons from leukaemia. Cell Prolif 2005;38:357-61.
33. Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma 2005;52:435-40.
34. Otto WR. Lung epithelial stem cells. J Pathol 2002;197:527-35.
35. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-35.